Altimmune Inc (ALT)

Currency in USD
4.29
+0.09(+2.14%)
Closed·
After Hours
4.290.00(-0.02%)
·

ALT Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.26 / -0.38
Revenue / Forecast
5.00K / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.311--/833----Free Sign Up
03/2025-0.26/-0.385K/--+31.58%--Free Sign Up
12/2024-0.33/-0.345K/714M+2.94%-100%Free Sign Up
09/2024-0.32/-0.365K/833M+11.11%-100%Free Sign Up
06/2024-0.35/-0.3495K/714-0.4%+600.28%Free Sign Up
03/2024-0.34/-0.385K/--+10.53%--Free Sign Up
12/2023-0.54/-0.4437K/2.14K-22.73%+1,628.97%Free Sign Up
09/2023-0.39/-0.45362K/857M+13.33%-99.96%Free Sign Up
06/2023-0.32/-0.476K/3K+31.91%+100%Free Sign Up
03/2023-0.4/-0.521K/500M+20%-100%Free Sign Up

All numbers in USD

Altimmune Inc Earnings Call Summary for Q1/2025

  • Altimmune reported Q1 2025 EPS of -$0.26, beating expectations of -$0.38, with revenue at $5 million and net loss narrowing to $19.6 million
  • Stock price fell 4.33% post-earnings to $5.75, despite better-than-expected results; company maintains strong liquidity with current ratio of 13.11
  • Focus remains on pembidutide development for NASH, with Phase III trial expected in early 2026; additional trials planned for alcohol-related disorders
  • Company raised $35 million through ATM facility in Q1, ending quarter with $150 million cash; R&D expenses decreased to $15.8 million from $21.5 million YoY
  • Management expressed confidence in pembidutide's potential as a 'complete solution for NASH treatment,' citing efficacy and speed of action
Last Updated: 13/05/2025, 14:46
Read Full Transcript

FAQ

What Is Altimmune's Earnings Per Share (TTM)?

The Altimmune EPS (TTM) is -1.25.

When Is The Next Altimmune Earnings Date?

Altimmune will release its next earnings report on 06 Aug 2025.

What Is Altimmune’s Revenue Forecasts For Upcoming Quarters?

Altimmune’s revenue forecast is 833.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.